Understanding more precisely the nuances of performing target capture translates directly into obtaining the most clarity from your data during downstream analysis. To complement the evolving next-generation sequencing (NGS) workflow (Figure 1) and suite of target enrichment products IDT offers, here our research scientists provide specific guidelines to achieve reliable, repeatable results with our xGen hybridization capture protocol (xGen hybridization capture of DNA libraries).
Figure 1. NGS workflow overview. The NGS workflow involves preparing the DNA library followed by target enrichment, then sequencing samples on a compatible platform and computationally mapping reads against a reference genome during data analysis.
Tips to improve NGS target capture
- Use the family of xGen NGS products to achieve the best results. These include the xGen Lockdown Probes and Panels, xGen Blocking Oligos, xGen Dual Index UMI Adapters—Tech Access, xGen Hybridization and Wash Kit, xGen Library Amplification Primer Mix—to achieve the best results. For custom probes, use the IDT Target Capture Probe Design & Ordering Tool. The xGen hybrid capture system was specifically optimized to deliver robust and reproducible NGS result data.
- Select the appropriate xGen Blocking Oligos for your Nextera or TruSeq library type. xGen Blocking Oligos differ for Nextera and TruSeq libraries. By using the correct xGen Blocking Oligos, and not substituting with other blocking oligos, you can significantly improve overall capture performance.
- If your experiment focuses on non-human library captures, realize that Human Cot DNA might not be optimal.
For the best results, use alternatives like mouse Cot DNA, or Salmon sperm DNA.
- Ensure lab instruments used in the protocol have been recently calibrated. Even small changes in temperature (+/- 2°C) for hybridization reactions and washes have an impact on the flanked-on target percentage and GC bias. Skewed GC bias in NGS data is a known indicator for poor capture uniformity, thus calibration is an important consideration. A hotter wash temperature leads to drop-out of low GC regions from capture. A colder wash temperature leads to a lower on-target percentage.
Note: For target enrichment sequencing it is important to quantify how many of your sequencing reads were on-target verses off-target. The simplest approach is to calculate the number of aligned bases on your target region. However, this can be complicated to apply across libraries with different insert lengths. For example, if one of your targets is a 150 bp read and the insert is 150 bp, then your on-target bases would be 100%. Meanwhile, a larger 300 bp read, aligned to the same 150 bp target, would mean that only 50% of the bases are on-target. To simplify the analysis, and compare across diverse samples, the target region is usually padded (150 bp in either direction) to calculate bases flanked on-target (Figure 2).
Figure 2. Flanked on-target sequencing analysis. During data analysis across diverse samples, a commonly used method to determine how many sequencing reads are on-target versus off-target is to pad your target region before calculating the flanked on-target bases.
- We recommend using the plate protocol when processing multiple samples. Using the plate protocol (versus the tube protocol) shows lower sample-to-sample variability within one experiment.
- When working with plates, avoid using the wells on the perimeter of the plate’s edges. Evaporation is more likely to occur in these outer rows.
- Always ensure that the hybridization reaction tube or plate is tightly sealed.
Evaporation of the hybridization reaction can lead to capture failure.
Note: Optimization of the sealing method might be necessary if heat sealers are used.
- Extending hybridization incubation time from 4 to 16 hours may improve panel performance, particularly for smaller panels (< 1,000 probes).
- Preheat the “heated wash buffers” a minimum of 15 minutes before use.
Preheating helps ensure there is sufficient time to heat the buffers to 65°C at critical steps during the protocol.
- When using the optional Appendix A: AMPure XP Bead DNA concentration protocol, make sure that no SPRI beads are accidentally carried over into the hybridization reaction.
Bead carryover has negative impact on flanked on-target percentage and probe coverage.
- Understand that the optional Appendix A: AMPure XP Bead DNA concentration protocol requires more Human Cot DNA than the standard SpeedVac method.
Additional Human Cot DNA (IDT Cat# 1080768; 1080769) must be purchased separately from the xGen Hybridization and Wash Kit. Using a standard amount of Human Cot DNA with AMPure XP Bead DNA concentration protocol can lead to lower flanked on-target percentage due to loss of small human Cot DNA fragments (50–300 bp fragment size) during AMPure XP concentration.
- Vortex every 10 to 12 minutes during the 45-minute bead capture to improve the kinetics of the capture.
- Do not let the Streptavidin beads dry out at any point during the protocol.
If necessary, extend washes slightly rather than let the beads dry out.
- Ensure the Streptavidin beads remain fully resuspended during room temperature washes.
Vortex vigorously and adhere to the incubation guidelines during room temperature washes to improve data quality.
Note: Bead splashing on the plate seal has no negative impact on capture results.
- Always use fresh seals in each step of the protocol that calls for adhesive seals on plates.
Using fresh seals avoids possible sample cross-contamination during the plate protocol.
The IDT xGen hybridization capture of DNA libraries protocol specifies the guidelines and required steps to follow for target enrichment of a library prepared from genomic DNA. Expect the best results when used with the accompanying xGen Lockdown Probes or Panels. Use the xGen Universal Blockers to reduce nonspecific binding of adapter arms. Let these reliable products and protocol guidelines equip you for success in your NGS target enrichment applications.
Learn more about the xGen family of hybridization capture products
SPRI and AMPure are trademarks of Beckman Coulter, Inc. and are registered in the USPTO. TruSeq and Nextera are trademarks of Illumina Inc., registered in the U.S. and other countries. xGen and Lockdown are trademarks of Integrated DNA Technologies, Inc.